Cargando…
Finding all BRCA pathogenic mutation carriers: best practice models
Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucial component in the medical management of affected patients. Furthermore, the relatives of affected patients can be offered genetic testing. Relatives who test positive for a germline BRCA pathogenic m...
Autores principales: | Hoogerbrugge, Nicoline, Jongmans, Marjolijn CJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141577/ https://www.ncbi.nlm.nih.gov/pubmed/27514840 http://dx.doi.org/10.1038/ejhg.2016.95 |
Ejemplares similares
-
Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008) -
Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010) -
Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018) -
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011) -
Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
por: Visser, Annemiek, et al.
Publicado: (2011)